MSF Trial Finds Better Treatment For People With TB
December 22, 2022
December 22, 2022
NEW YORK, Dec. 22 (TNSjou) -- The Doctors Without Borders/Medecins Sans Frontieres issued the following news on Dec. 21, 2022:
A new all-oral, six-month treatment regimen is safer and more effective at treating multidrug-resistant tuberculosis (MDR-TB) than the current options, according to results of a Doctors Without Borders/Medecins Sans Frontieres (MSF) study published in the New England Journal of Medicine today. These findings come from MSF's TB PRACTECAL, the first-ever . . .
A new all-oral, six-month treatment regimen is safer and more effective at treating multidrug-resistant tuberculosis (MDR-TB) than the current options, according to results of a Doctors Without Borders/Medecins Sans Frontieres (MSF) study published in the New England Journal of Medicine today. These findings come from MSF's TB PRACTECAL, the first-ever . . .